Yes.
I went through the entire timeline of this company.
Continues to be overvalued and has provided barely any return to shareholders across that timeline. Some even in deep red.
CMS Proposes Major Increase in Reimbursement for Canaloplasty, page-365
-
- There are more pages in this discussion • 143 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add EYE (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
18.5¢ |
Change
-0.005(2.63%) |
Mkt cap ! $42.37M | |||
| Open | High | Low | Value | Volume |
| 19.0¢ | 19.0¢ | 18.5¢ | $4.318K | 22.75K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 129897 | 18.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 19.0¢ | 6009 | 2 |
View Market Depth
| Last trade - 16.10pm 16/10/2024 (20 minute delay) ? |
| EYE (ASX) Chart |